You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Chronic liver disease

Semaglutide for treating metabolic dysfunction-associated steatohepatitis with liver fibrosis [ID6458]

  • In development
  • Reference number: GID-TA11477
  • Expected publication date: TBC
  • Project information
  • Project documents

On this page

  1. Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6458
  2. Referral
  3. Topic selection

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6458

  • Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 6458

  • Draft scope post referral (PDF 109 KB)

    Published:
    17 April 2025
  • Draft matrix post referral (PDF 46 KB)

    Published:
    17 April 2025

Referral

  • Referral

Topic selection

  • Topic selection

Back to top